Amylin effect in extrapancreatic tissues participating in glucose homeostasis, in normal, insulin-resistant and type 2 diabetic state

Peptides

Volumn 32, Issue 10, 2011, Pages 2077-2085

  Moreno, P ^a,b   Acitores, A ^a,b   Gutierrez Rojas I ^a,b   Nuche Berenguer, B ^a,b   Assar, M El ^c   Rodriguez Manas L ^c   Gomis, R ^b,d   Valverde, I ^a,b   Visa, M ^c,d   Malaisse, W J ^e   Novials, A ^b,d   Gonzalez N ^a,b   Villanueva Penacarrillo M L ^a,b  

^a 28400 Madrid   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Amylin; Diabetes; Insulin resistance

Indexed keywords

AMYLIN; GLUCOSE; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 4; GLYCOGEN; GLYCOGEN SYNTHASE; INSULIN; MESSENGER RNA; PROTEIN;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; GLYCOGEN ANALYSIS; GLYCOGEN LIVER LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MUSCLE LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; RAT; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; GLUCOSE TRANSPORTER TYPE 2; GLUCOSE TRANSPORTER TYPE 4; GLYCOGEN; GLYCOGEN SYNTHASE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; ISLET AMYLOID POLYPEPTIDE; MALE; RATS; RATS, WISTAR;

ANIMALIA; RATTUS NORVEGICUS;

EID: 80054052492     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2011.09.007     Document Type: Article

References (53)

1. B. Ahrén, C. Oostewijk, C.J. Lips, and J.W. Höppener Transgenic overexpression of human islet amyloid polypeptide inhibits insulin secretion and glucose elimination after gastric glucose gavage in mice Diabetologia 41 1998 1374 1380 (Pubitemid 28488767)
2. L. Arnés, P. Moreno, B. Nuche-Berenguer, I. Valverde, and M.L. Villanueva-Peñacarrillo Effect of exendin-4 treatment upon glucose uptake parameters in rat liver and muscle, in normal and type 2 diabetic state Regul Pept 153 2009 88 92
3. C. Ascencio, N. Torres, F. Isoard-Acosta, F.J. Gómez-Pérez, R. Hernández-Pando, and A.R. Tovar Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats J Nutr 134 2004 522 529 (Pubitemid 38298490)
4. S.W. Barth, T. Riediger, T.A. Lutz, and G. Rechkemmer Differential effects of amylin and salmon calcitonin on neuropeptide gene expression in the lateral hypothalamic area and the arcuate nucleus of the rat Neurosci Lett 341 2003 131 134 (Pubitemid 36398486)
5. J. Cancelas, P.G. Prieto, M. García-Arévalo, V. Sancho, M.L. Villanueva-Peñacarrillo, and W.J. Malaisse Induction and reversibility of insulin resistance in rats exposed to exogenous d-fructose Horm Metab Res 40 2008 459 466
6. S. Casa, R. Gomis, F.M. Gribble, J. Altirriba, S. Knuutila, and A. Novials Impairment of the ubiquitin-proteasome pathway is a downstream endoplasmic reticulum stress response induced by extracellular human islet amyloid polypeptide and contributes to pancreatic beta-cell apoptosis Diabetes 56 2007 2284 2294 (Pubitemid 47358235)
7. G. Christopoulos, K.J. Perry, M. Morfis, N. Tilakaratne, Y. Gao, and N.J. Fraser Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product Mol Pharmacol 56 1999 235 242 (Pubitemid 29309833)
8. Y. Chun, and Z.D. Yin Glycogen assay for diagnosis of female genital Chlamydia trachomatis infection J Clin Microbiol 36 1998 1081 1082 (Pubitemid 28146301)
9. G.J.S. Cooper Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metobolic disease Endocr Rev 15 1994 163 201 (Pubitemid 24129182)
10. G.J. Cooper, B. Leighton, G.D. Dimitriadis, M. Parry-Billing, J.M. Kowalchuk, and K. Howland Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle Proc Natl Acad Sci 85 1988 7763 7766
11. P. Dégano, R. Silvestre, M. Salas, E. Peiró, and J. Marco Amylin inhibits glucose-induced insulin secretion in a dose-dependent manner study in the perfused rat pancreas Regul Pept 22 1993 91 96
12. K.C. Dunican, N.M. Adams, and A.R. Desilets The role of pramlintide for weight loss Ann Pharmacother 44 2010 538 545
13. M. Fineman, C. Weyer, D.G. Maggs, S. Strobel, and O.G. Kolterman The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus Horm Metab Res 34 2002 504 508 (Pubitemid 35192237)
14. B.R. Gedulin, T.J. Rink, and A.A. Young Dose-response for glucagonostatic effect of amylin in rats Metabolism 46 1997 67 70 (Pubitemid 27052027)
15. L. Haataja, T. Gurlo, C.J. Huang, and P.C. Butler Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis Endocr Rev 29 2008 303 316 (Pubitemid 351679701)
16. V. Herbert, K.S. Lau, C.W. Goltlieb, and S.J. Bleicher Coated charcoal inmunoassay of insulin J Clin Invest 25 1956 1375 1384
17. J.J. Hillebrand, and N. Geary Do leptin and insulin signal adiposity? Forum Nutr 63 2010 111 122
18. J. Höppener, B. Ahren, and C. Lips Islet amyloid popypeptide and type 2 diabetes mellitus New Engl J Med 343 2000 411 419 (Pubitemid 30626125)
19. D.M. Huffman, G.W. McLean, and M.A. Seagrove Continuous subcutaneous pramlintide infusion therapy in patients with type 1 diabetes: observations from a pilot study Endocr Pract 15 2009 689 695
20. B. Isaksson, F. Wang, J. Permert, M. Olsson, B. Fruin, and M.K. Herrington Chronically administered islet amyloid polypeptide in rats serves as an adiposity inhibitor and regulates energy homeostasis Pancreatology 5 2005 29 36 (Pubitemid 40674587)
21. S.E. Kahn, D.A. DAlessio, M. Schwartz, W.Y. Fujimoto, J.W. Ensinck, and G. Taborsky Evidence of cosecretion of islet amyloid polypeptide and insulin by beta cells Diabetes 39 1990 634 638 (Pubitemid 20223792)
22. M.T. Kailasam, R.J. Parmer, E.A. Tyrell, R.R. Henry, and D.T. O-Connor Circulating amylin in human essential hypertension: heritability and early increase in individuals at genetic risk J Hypertens 18 2000 1611 1620
23. A. Kautzky-Willer, K. Thomaseth, B. Ludvik, P. Nowotny, D. Rabensteiner, and W. Waldhäusl Elevated islet amyloid polypeptide and proinsulin in lean gestational diabetes Diabetes 46 1997 607 614 (Pubitemid 27143376)
24. S.J. Koopmans, A.D. Van Mansfeld, H.S. Jansz, H.M. Krans, J.K. Radder, and M. Frölich Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues Diabetologia 34 1991 218 224
25. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
26. H.E. Lebovitz Adjunct therapy for type 1 diabetes mellitus Nat Rev Endocrinol 6 2010 324 326
27. J.D. Leffert, C.B. Newgard, H. Okamoto, J.L. Milburn, and K.L. Luskey Rat amylin: cloning and tissue-specific expression in pancreatic islets Proc Natl Acad Sci U S A 9 5 1989 789 790
28. T.A. Lutz Pancreatic amylin as a centrally acting satiating hormone Curr Drug Target 6 2005 181 189 (Pubitemid 40394313)
29. T.A. Lutz The role of amylin in the control of energy homeostasis Am J Physiol Regul Integr Comp Physiol 298 2010 R1475 R1484
30. C. Mack, J. Wilson, J. Athanacio, J. Reynolds, K. Laugero, and S. Guss Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight Am J Physiol Regul Integr Comp Physiol 293 2007 R1855 R1863
31. J.M. Molina, G.J.S. Cooper, B. Leighton, and J.M. Olefsky Introduction of insulin resistance in vivo by amylin and calcitonin gene-related peptide Diabetes 39 1990 260 265 (Pubitemid 20054296)
32. M. Morales, M.I. López-Delgado, A. Alcántara, M.A. Luque, F. Clemente, and L. Márquez Preserved GLP-1 effects on glycogen synthase a activity and glucose metabolism in isolated hepatocytes and skeletal muscle from diabetic rats Diabetes 48 1997 1264 1269 (Pubitemid 27315273)
33. A. Novials, Y. Sarri, R. Casamitjana, F. Rivera, and R. Gomis Regulation of islet amyloid polypeptide in human pancreatic islets Diabetes 42 1993 1514 1519 (Pubitemid 23277210)
34. A. Novials, L. Rodriguez-Mañas, A. Chico, M. El Assar, S. Casas, and R. Gomis Amylin and hypertension: association of an amylin -G132A gene mutation and hypertension in humans and amylin-induced endothelium dysfunction in rats J Clin Endocrinol Metab 92 2007 1446 1450 (Pubitemid 46556424)
35. B. Nuche-Berenguer, P. Moreno, P. Esbrit, S. Dapía, J.R. Caeiro, and J. Cancelas Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states Calcif Tissue Int 84 2009 453 461
36. T. Osaka, A. Tsukamoto, Y. Koyama, and S. Inoue Central and peripheral administration of amylin induces energy expenditure in anesthetized rats Peptides 29 2008 1028 1035
37. A. Perea, C. Viñambres, F. Clemente, M.L. Villanueva- Peñacarrillo, and I. Valverde GLP-1 (7-36) amide: effects on glucose transport and metabolism in rat adipose tissue Horm Metab Res 29 1997 417 421
38. T.R. Pieber, J. Roitelman, Y. Lee, K.L. Luskey, and D.T. Stein Direct plasma radioimmunoassay for rat amylin-(1-37): concentrations with acquired and genetic obesity Am J Physiol Endocrinol Metab 267 1994 E156 E164
39. B. Portha, L. Picon, and G. Rosselin Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes Diabetologia 17 1979 371 377 (Pubitemid 10219170)
40. T. Riediger, D. Zued, C. Becskei, and T.A. Lutz The anoretic hormone amylin contributes to feeding-related changes of neuronal activity in key strcutures of the gut-brain axis Am. J Physiol Regul Integr Comp Physiol 286 2004 R114 R122
41. M. Rodbell Metabolism of isolated fat cells I. Effects of hormones on glucose metabolism and lipolysis J Biol Chem 239 1964 375 380
42. J.D. Roth, B.L. Roland, R.L. Cole, J.L. Trevaskis, C. Weyer, and J.E. Koda Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies Proc Natl Acad Sci U S A 105 2008 7257 7262 (Pubitemid 351754465)
43. P.A. Rushing, M.M. Hagan, R.J. Seeley, T.A. Lutz, and S.C. Woods Amylin: a novel action in the brain to reduce body weight Endocrinology 141 2000 850 853 (Pubitemid 32250511)
44. V. Sancho, M.V. Trigo, N. González, I. Valverde, W.J. Malaisse, and M.L. Villanueva-Peñacarrillo Effects of GLP-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats J Mol Endocrinol 35 2005 27 38 (Pubitemid 41167623)
45. M.W. Schwartz, S.C. Woods, R.J. Seeley, G.S. Barsh, D.G. Baskin, and R.L. Leibel Is the energy homeostasis system inherently biased toward weight gain? Diabetes 52 2003 232 238 (Pubitemid 36173173)
46. R.A. Silvestre, J. Rodríguez-Gallardo, C. Jodka, D.G. Parkes, R.A. Pittner, and A.A. Young Selective amylin inhibition of the glucagon response to arginine is extrinsic to the pancreas Am J Physiol Endocrinol Metab 280 2001 E443 E449
47. T. Tokuyama, K. Yagui, T. Yamaguchi, C.I. Huang, N. Kuramoto, and F. Shimada Expression of human islet amyloid polypeptide/amylin impairs insulin secretion in mouse pancreatic beta cells Metabolism 46 1997 1044 1051 (Pubitemid 27371822)
48. I. Valverde, M. Barreto, and W.J. Malaisse Stimulation by d-glucose of protein biosynthesis in tumoral insulin-producing cells (RINm5F line) Endocrinology 122 1988 1443 1448 (Pubitemid 18091975)
49. M.L. Villanueva-Peñacarrillo, A. Alcántara, F. Clemente, E. Delgado, and I. Valverde Potent glycogenic effect of GLP-1 (7-36) amide in rat skeletal muscle Diabetologia 37 1994 1163 1166
50. M.L. Villanueva-Peñacarrillo, J. Puente, A. Redondo, F. Clemente, and I. Valverde Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models Endocrine 15 2001 241 248 (Pubitemid 32977337)
51. W. Vine, K. Beaumont, B. Gedulin, R. Pittner, C.X. Moore, and T.J. Rink Lactate production from the rat hindlimb is increased after glucose administration and is suppressed by a selective amylin antagonist: evidence from action of endogenous amylin in skeletal muscle Biochem Biophys Res Commun 216 1995 554 559
52. S.C. Woods Signals that influence food intake and body weight Physiol Behav 86 2005 709 716 (Pubitemid 41728989)
53. A.A. Young, B.R. Gedulin, and T.J. Rink Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake Metabolism 45 1996 1 3 (Pubitemid 26104260)